Today we interviewed Phill Jones of AsisChem. In this interview we approached clinical trials from a pre-clinical perspective, which is what Phill is very knowledgeable on. It is important to understand that before clinical trials ever begin on a molecule that the molecule must first be synthesized. This is where Phill and his company come into the picture. We will definitely do a part 2 of this interview due to the poor audio quality towards the end of the video. We hope you can still gain some greater insight on this topic! You may also reach Phill at phill.b.jones@gmail.com or on LinkedIn. Phile also recommends you check out these websites as well: The Journal of Visualized Experiments (JoVE), the world’s first peer-reviewed video journal.











Follow Us:
Subscribe
Questions or Concerns? Please call (888) 264-4723